Patents by Inventor Anna SOBIERAJ

Anna SOBIERAJ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250243266
    Abstract: The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
    Type: Application
    Filed: December 24, 2024
    Publication date: July 31, 2025
    Inventors: Leonardo BORRAS, Pankaj GUPTA, Stefan HOERER, Stephanie JUNGMICHEL, Christian LEISNER, Sophia REINDL, Philipp Robert RICHLE, Fabian SCHEIFELE, Anna SOBIERAJ
  • Patent number: 12344663
    Abstract: The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
    Type: Grant
    Filed: December 21, 2022
    Date of Patent: July 1, 2025
    Assignees: CDR-Life AG, Boehringer Ingelheim International GmbH
    Inventors: Leonardo Borras, Pankaj Gupta, Stephanie Jungmichel, Christian Leisner, Philipp Robert Richle, Fabian Scheifele, Anna Sobieraj
  • Publication number: 20230257455
    Abstract: The present invention relates to antibodies and fragments thereof that target the complement C3. More specifically, anti-C3 antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
    Type: Application
    Filed: December 21, 2022
    Publication date: August 17, 2023
    Inventors: Leonardo BORRAS, Pankaj GUPTA, Stefan HOERER, Stephanie JUNGMICHEL, Christian LEISNER, Sophia REINDL, Philipp Robert RICHLE, Fabian SCHEIFELE, Anna SOBIERAJ